Most active investors · Last 30 days
Ranked by rounds participated in, from announcements in Sep 17, 2026 – Oct 16, 2026. Lead counts include only confirmed lead roles.
Browse by month
1rounds
0led
Industrial tech 1
Seed 1
1rounds
1led
Defense tech 1
Seed 1
Details
1rounds
0led
Defense tech 1
Seed 1
Details
1rounds
0led
Developer tools 1
Pre-seed 1
Details
1rounds
0led
Cybersecurity 1
Pre-seed 1
Details
1rounds
0led
Developer tools 1
Series B 1
Details
1rounds
0led
Edtech 1
Seed 1
Details
1rounds
0led
Edtech 1
Seed 1
Details
1rounds
0led
Edtech 1
Seed 1
Details
1rounds
1led
AI 1
Pre-seed 1
Details
1rounds
0led
Cybersecurity 1
Pre-seed 1
Details
1rounds
0led
Developer tools 1
Series B 1
Details
1rounds
0led
AI 1
Pre-seed 1
Details
1rounds
0led
Edtech 1
Seed 1
Details
1rounds
1led
Healthtech 1
Undisclosed 1
Details
1rounds
0led
Enterprise software 1
Series A 1
Details
1rounds
0led
Developer tools 1
Series B 1
Details
1rounds
0led
Robotics 1
Series A 1
Details
1rounds
0led
Biotech 1
Undisclosed 1
Details
New companies 1 · Follow-on 0
Stages: Undisclosed 1
Molecular Targeting Technologies, Inc. $3.2M National Cancer Institute R01 grant1rounds
0led
Developer tools 1
Series B 1
Details
1rounds
0led
AI 1
Series A 1
Details
1rounds
0led
AI 1
Series A 1
Details
1rounds
0led
Cybersecurity 1
Pre-seed 1
Details
1rounds
0led
Fintech 1
Seed 1
Details
1rounds
0led
Developer tools 1
Series B 1
Details
1rounds
0led
Developer tools 1
Series B 1
Details
1rounds
0led
Defense tech 1
Seed 1
Details
1rounds
0led
Enterprise software 1
Seed 1
Details
1rounds
1led
Enterprise software 1
Series A 1
Details
1rounds
0led
Developer tools 1
Series B 1
Details
“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.